Cenderitide

DB11777InvestigationalProtein Based Therapies

Cenderitide is under investigation for the treatment of ST Elevation (STEMI) Myocardial Infarction of Anterior Wall.

Mechanism: Pharmacologically active on Atrial natriuretic peptide receptor 1, Atrial natriuretic peptide receptor 2, and Atrial natriuretic peptide receptor 3
Curator reviewed
Also known as: CD-NP

Resolves to

Compound

Targets

What you can answer from here — as of July 07, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

10Clinical trialsPhase, status and sponsor resolved per trial

13+ReferencesStructured and connected to the statements they support

Which drugs share a target with Cenderitide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.